Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Following your first consultation you will schedule a medication teaching visit as soon as you receive your medications
The TRIUMPH-1 Phase 3 clinical trial results, announced in May 2026, showcased participants losing up to 28.3% of their body weight over 80 weeks, indicating significant promise compared to other options like tirzepatide (Zepbound) and semaglutide (Wegovy)
Prioritize water as your primary beverage, aiming for at least 810 glasses daily to support kidney function and prevent dehydration
It has been shown to reduce damage to the energy producing mitochondria
This test maps 14 metabolic pathways across 49 peptides and 150+ genetic insights, helping your provider optimize your treatment plan based on your unique biology
US$ 27.04
US$ 28.57
:max_bytes(150000):strip_icc()/not-eating-signs-symptoms-5201896_final-c41f6a10844343059195cfb13e561098.jpg)
US$ 20.68
